Cargando…

Molecular signature of Epstein-Barr virus infection in MS brain lesions

OBJECTIVE: We sought to confirm the presence and frequency of B cells and Epstein-Barr virus (EBV) (latent and lytic phase) antigens in archived MS and non-MS brain tissue by immunohistochemistry. METHODS: We quantified the type and location of B-cell subsets within active and chronic MS brain lesio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moreno, Monica A., Or-Geva, Noga, Aftab, Blake T., Khanna, Rajiv, Croze, Ed, Steinman, Lawrence, Han, May H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994704/ https://www.ncbi.nlm.nih.gov/pubmed/29892607 http://dx.doi.org/10.1212/NXI.0000000000000466

Ejemplares similares

Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies
por: Bar-Or, Amit, et al.
Publicado: (2020)

Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: (Trends in Molecular Medicine, 26:3 p:296-310, 2020)
por: Bar-Or, Amit, et al.
Publicado: (2021)

Adoptive T‐cell therapy targeting Epstein–Barr virus as a treatment for multiple sclerosis
por: Smith, Corey, et al.
Publicado: (2023)

Epstein-Barr–negative MS: a true phenomenon?
por: Dobson, Ruth, et al.
Publicado: (2017)

Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis
por: Pender, Michael P., et al.
Publicado: (2020)

Epstein–Barr virus-associated nephrotic syndrome
por: Mikhalkova, Deana, et al.
Publicado: (2012)

Epstein-Barr Virus Associated Modulation of Wnt Pathway Is Not Dependent on Latent Membrane Protein-1
por: Webb, Natasha, et al.
Publicado: (2008)

Epstein-Barr Virus and Human Cancer
por: Young, Lawrence
Publicado: (2002)

Epstein–Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis
por: Pender, Michael P, et al.
Publicado: (2014)

Epstein-Barr virus and nasopharyngeal carcinoma
por: Young, Lawrence S., et al.
Publicado: (2014)

Induction and progression of human lymphoproliferative lesions by Epstein-Barr virus.
por: Chappuis, B B, et al.
Publicado: (1990)

Roadmap for understanding mechanisms on how Epstein–Barr virus triggers multiple sclerosis and for translating these discoveries in clinical trials
por: Lanz, Tobias V, et al.
Publicado: (2023)

Epstein-Barr virus at 50—future perspectives
por: Young, Lawrence S.
Publicado: (2014)

Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus
por: Navari, Mohsen, et al.
Publicado: (2014)

The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)

Brain MRI in Epstein–Barr Virus Meningoencephalitis in Children
por: Vyas, Sameer, et al.
Publicado: (2020)

Differential serostatus of Epstein-Barr virus in Iranian MS patients with various clinical patterns
por: Laribi, Bahareh, et al.
Publicado: (2018)

The Epstein Barr virus circRNAome
por: Ungerleider, Nathan, et al.
Publicado: (2018)

Transient asymptomatic white matter lesions following Epstein-Barr virus encephalitis
por: Jang, Yoon Young, et al.
Publicado: (2011)

Epstein - Barr virus Pneumonitis
por: McManus, Terence E, et al.
Publicado: (2009)

Epstein–Barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein–barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein-Barr virus and skin
por: Sangueza-Acosta, Martin, et al.
Publicado: (2018)

Epstein-Barr Virus Gastritis
por: Oki, Masayuki, et al.
Publicado: (2017)

Resurrecting Epstein–Barr Virus
por: Paganelli, Roberto
Publicado: (2022)

Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain
por: Serafini, Barbara, et al.
Publicado: (2007)

Detection of Epstein-Barr virus in recurrent tonsillitis
por: Dias, Eliane Pedra, et al.
Publicado: (2015)

Prevention of MS Requires Intervention on the Causes of the Disease: Reconciling Genes, Epigenetics, and Epstein Barr Virus
por: Kearns, Patrick K. A.
Publicado: (2022)

Endogenous Presentation of CD8(+) T Cell Epitopes from Epstein-Barr Virus–encoded Nuclear Antigen 1
por: Tellam, Judy, et al.
Publicado: (2004)

Recent Advances on the Possible Neuroprotective Activities of Epstein-Barr Virus Oncogene BARF1 Protein in Chronic Inflammatory Disorders of Central Nervous System
por: Wynne, Alicia, et al.
Publicado: (2010)

Dendritic Cells Initiate Immune Control of Epstein-Barr Virus Transformation of B Lymphocytes In Vitro
por: Bickham, Kara, et al.
Publicado: (2003)

Potential Cellular Functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus
por: Smith, Danielle Westhoff, et al.
Publicado: (2013)

Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
por: Wongwiwat, Wiyada, et al.
Publicado: (2022)

Epstein–Barr virus (EBV)-associated epithelial and non-epithelial lesions of the oral cavity
por: Kikuchi, Kentaro, et al.
Publicado: (2017)

Evaluation of reactive Epstein–Barr Virus (EBV) in Iranian patient with different subtypes of multiple sclerosis (MS)
por: Ramroodi, Nourollah, et al.
Publicado: (2013)

An Epstein-Barr virus-associated superantigen
Publicado: (1996)

Macular Amyloidosis and Epstein-Barr Virus
por: Nahidi, Yalda, et al.
Publicado: (2016)

Epstein-Barr virus infection mechanisms
por: Chesnokova, Liudmila S., et al.
Publicado: (2014)

Epstein-Barr Virus Neurologic Complications
por: Millichap, J. Gordon
Publicado: (2015)

Epstein–Barr virus latent genes
por: Kang, Myung-Soo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2dm4osd3nub20oo5a23mlv6h3c